The Application of Electroporation to Transfect Hematopoietic Cells and to Deliver Drugs and Vaccines Transcutaneously for Cancer Treatment
Author:
Open Access
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 1 (5) , 373-384
Abstract
Electroporation and the associated phenomenon of electrofusion have been widely adapted as tools to a broad range of biomedical research and therapy. In this article, we summarize our adaptation of the electroporation and electrofusion technology in two fronts of cancer research and treatment. The first is genetic manipulation of hematopoietic cells for the purpose of cancer treatment. High efficiency transfection methods have been developed to transfect NK cells, peripheral blood stem cells, and bone marrow derived dendritic cells. Hybrids of tumor cells and bone marrow derived dendritic cells have been formed by electrofusion for the purpose of tumor vaccines. The second front is the use of transcutaneous electroporation to deliver anticancer drugs and vaccines across the skin. Methods to extend the upper molecular weight limit of transcutaneous electroporation have been developed. The pro-photosensitizer drug, δ-amino levulinic acid, the anticancer drug methotrexate, and peptide vaccines designed for cancer prevention and immunotherapy have been delivered transcutaneously by electroporation. These studies hold promise for the treatment of cancers in human.Keywords
This publication has 57 references indexed in Scilit:
- Efficient expression of foreign genes in human CD34+ hematopoietic precursor cells using electroporationGene Therapy, 2001
- High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene deliveryGene Therapy, 2000
- Local transport regions (LTRs) in human stratum corneum due to long and short `high voltage' pulsesBioelectrochemistry and Bioenergetics, 1998
- Skin Electroporation: Rapid Measurements of the Transdermal Voltage and Flux of Four Fluorescent Molecules show a Transition to Large Fluxes Near 50VJournal of Pharmaceutical Sciences, 1998
- A proof of glutathione S-transferase-π-related multidrug resistance by transfer of antisense gene to cancer cells and sense gene to bone marrow stem cellChemico-Biological Interactions, 1998
- Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8Human Immunology, 1997
- Depth-Targeted Efficient Gene Delivery and Expression in the Skin by Pulsed Electric Fields: An Approach to Gene Therapy of Skin Aging and Other DiseasesBiochemical and Biophysical Research Communications, 1996
- Factors affecting transdermal delivery of metoprolol by electroporationBioelectrochemistry and Bioenergetics, 1995
- Transdermal Transport of DNA Antisense Oligonucleotides by ElectroporationBiochemical and Biophysical Research Communications, 1995
- Permeability changes induced by electric impulses in vesicular membranesThe Journal of Membrane Biology, 1972